Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Not if Doug made an annoucement he was not suppose to make that the results would be presented at the conference (May 4). Apparently that needed to be retracted. Yes, lawyers are very conservative. Prosecutors generally only take cases that are slam-dunks. But it is better to avoid these issues all together.
Doug had to sell his shares because Doug got advanced information about Isradipine and would then be subject to getting advanced information to profit off of and the SEC would be knocking on his door. He had to sell his shares to avoid conflict of interest and he had to do it before the announcement. He will get his shares back after the isradipine announcement. He won't lose that much money but more importantly ELTP will look clean and Nasrat will avoid investigation by the SEC. Very smart Nasrat and ELTP. This may also explain why Nasrat did not get paid in more shares. I am not sure of the timing but Nasrat may not have gotten more shares since the Isradpine study was completed because he may have gotten inside information about the results.
It is highly unlikely we get a CRL because this is a generic of Adderall. FDA requirements are far less strenuous. It is not like a brand new unknown drug.
Ok- lets say an old drug for a new purpose.
I strongly suspect that the sales of Isradipine will begin to increase after the May meeting.But it will not be instant millions. Anyone familiar with the Pharm. Industry knows that acceptance of a new drug takes time. It is hard to change the rx patterns of MDs and what they are used to working with for one. Educating patients is another problem and they are stupid. Just look at vaccines-how crazy is that and look how long it has taken for people to realize the benefits far out way the risk. There is no perfect drug. Even water can kill a patient if they overdose on it. But as more patients are informed and demand Isradipine the more accepted it will become. Generating false fears and misinformation is a specialty of certain posters on this board. People read what is in front of them but they never dig deeper. This is a problem in the Pharm Industry as well as politics. Voltaire had a famous quote about voters-- something like thank goodness they have very short memories.
Other than the results were announced to be presented in early May at the conference I have not seen the schedule and do not know the "exact" time of the presentation. This is because the schedule was already printed and sent out to attendees. These schedules are usually done about one year in advance. So your guess is as good as mine.
Isradipine will be successful or the people running the upcoming conference in May would not have allowed them to speak after they closed the conference for new speakers and set the schedule for the current speakers. This just does not usually happen and especially if the results were discouraging.
Bartrab- I agree. We are almost there as far as a profit goes. I think the next Q will show a PCF. It just takes a long long time to go through all the hoops from a patent, to research trials, to FDA, to marketing. I have always maintained this will suddenly end in a buyout but then it will be too late. So Buy, hold, accumulate.
I believe Imanjen. When your paid on the side to keep the stock within a certain range more than you could make on volume selling, this is what you get. Many fake 500,000 bids come and go quickly on/off the screen. Why do you think when there is a positive good Q report the stock goes down without fail every time?
Early this morning you could tell right away before the opening that they were going to try to hold this down by the fact that they drew the redline on the graph on the right side of the screen at the top of the chart signaling they were going to push it down as much as possible. Now ,in reality, we are only talking a few hundredths to thousandths of a penny but it looks like a big amount on the chart.
MMs are suppose to work on volume and facilitate trading. Not here. MMs trying to hold back by slowly filling orders, maintaining a downward pressure as much as they can. MMs getting paid not to make trades. BigP and MMs are fighting a losing battle. Of course, it does not help that no one is willing to sell so you would think the logical thing to do is to raise the SP. But no! Too logical. Won't last for too much longer.
Dear JJ-Let me assure you it is not Nasrat!!!!Catch and kill takes many forms in our lives- from murder, to killing an unfavorable news releases, to killing small pharmas with great ideas and new drugs. Nasrat has had years of experience in BigP at the highest levels and knows how to play all the games. Nasrat could have sold us out long long ago and not gone through all that he has gone through for ELTP.He was already a millionaire when he got to ELTP. When great ideas come along that are game changing technology from car engines that run on ordinary water to great ideas in new medications, existing companies who are threatened by new technology will try to buyout that company and prevent or delay its production or simply put it on the shelf. Additionally, if the company resists playing the usual games or going along with Big P, they can try to destroy the company. Nasrat is fully aware of this as he has done this to many small companies when he worked for BIgP. BigP can bribe the FDA to require a little company to jump through many hoops while putting financial pressure on the company through MMs, dark markets, dark money, overseas hedge funds in an effort to destroy the company. Just go to Google and type in bribes and the FDA. You will be shocked. Nasrat will win!! His strategy is outstanding. While fighting BigP over Sequestox he has developed many other drugs to increase the value of the company and pay for Sequestox. He will win because political pressure will be applied to BigP and the FDA. After Purdue, the FDA could be next on the hit list. The public will demand Sequestox. MM's and BigP know they are losing and it did not go as planned with ELTP because Nasrat is so smart. Every once in a while a small OTC company can rise above BigP and MM's and all the financial intrigue and games. This will happen to ELTP.
IB- Totally agree.
Wrong again! 473,000 before lunch is good volume based on the average daily volume of 525,000. Of course we would really like to see 2 million daily average (going up).
IB- Sounds logical to me so why is the FDA so so incredibly stupid in even requesting an IV study be done. Lets just tell the FDA to crush and filter. Maybe they can try it out on each other and then vote for approving Sequestox while taking Percocet. It should pass and we would be done with this stupid BS which is my main point. Again a dumb ass labeling issue.
I do not think Nasrat is going to do his IV testing by stuffing Sequestox up the assholes of rats. BigP has failed to come up with anything better than Sequestox but the FDA is demanding it. BigP spent millions buying the rights to patents and trying to further develop the heat extruding process to make it work but failed. Even if BigP developed something different it would take 10 years minimal to get it to market. By then ELTP will have made enough money to make an even better drug and Sequestox will still be on the market as a replacement for opioids no matter what happens.
DR Ryan- Great observation. We are seeing MM delay tactics.
After crushing Sequestox, the drug would not work. It has always been a silly labeling issue ever since the previous woman FDA administrator said it was just a labeling issue. Just change the label and we are good. Same thing today. Just label it "Not for Injection". Well, maybe Nasrat will take your suggestion and filter it through cotton and then inject it. So I guess we should put on the label "For injection after filtering with cotton but the drug won't work."
Nasrat could easily get around the IV testing by going at it at a different angle. Obviously both Percocet and Naltrexone have previously passed the FDA insepection and are both widely used today. If their were a legitimate concern from the FDA about Sequestox it would be the following. Some stupid drug addict would try to grind up Sequestox and inject it. Obviously that would neutralize the Percocet for no gain for the addict. But they are stupid enough to try that. So the real question would be what would happen to the plastic coating if it were injected into the bloodstream. Of course, in the stomach this would be digested and dissolved. So even taking some rats and injecting a dose equivalent into the blood stream could be a simple test. But really it just boils down to putting on the label "Not for Injection". How incredibly stupid the FDA has exposed themselves to be and how politically motivated they are though bribes.
Nasrat is working on the IV study for Sequestox. While I am not a chemist it will be interesting to see how they make Sequestox into an IV solution. Of importance is a distributor for Sequestox. It obviously cannot be a BigP involved in a lawsuit. The Chinese are under scrutiny for Fentynl which makes them a little questionable as well. Nasrat has tough choices but with options to consider ahead of him.
JJ- I agree with your premise about lawsuits and I have expressed the same concern in previous posts myself. ELTP does need to make their own Percocet,etc just as a part of being able to manufacture Sequestox as one of the ingredients needed. ELTP does have a hedge in this bet in that they are making Sequestox which has been needlessly delayed by the FDA. Remember Sequestox was technically approved by a previous woman heading up the FDA but not finalized because she was removed from office. ELTP in a lawsuit could always say we need Percocet to make Sequestox which has been delayed by the FDA for the most ridiculous reasoning. This could be a PR advantage and a kick in FDA butts to get this approved since the FDA has been PRing their heads off about creating Sequestox medications. Sequestox is just another step in the right direction and once approved will be around for many many years just like opioids which have been with us for thousands of years. So their is a PR and legal advantage for carefully going forward with Sequestox.
I do not think a drug addict is going to take the time it takes to separate the beads but they will find easier sources I am sure. I am not sure how Nasrat is even going to make an injectable form of Sequestox for the FDA test. I do not think beads will be very injectable although I have never seen a bead of Sequestox- but just saying. If they are separated it makes no sense to do the test because you will just be injecting straight narcotic or straight naloxone. Then the result would be no pain relief. It makes the testing null and void. It will be interesting to see how Nasrat is going to make an injectable form of Sequestox. That would be an accomplishment I am sure the drug addicts would like to know.
First of all I read the article and did not see any statement that it could be defeated. I remember 2 or 3 posts in the past showing how it could be defeated but no addicted person could afford the equipment or have the knowledge it would take to separate the beads. It is absolutely not going to happen on the street.
Just a little profit taking and usual lunch time dip.
This chip just gets rid of the tremors associated with PD but it does not cure it. People with back pain have gotten spinal stimulators implanted to control pain. It works on the same idea but now they have reduced the spinal stimulator to an implantable micro chip. You can reduce the tremors by externally applying something called the Alpha Stim to the head and get the same results.
Over the last several days we have seen long periods in the afternoon where the stock did not move. The market makers were taking a break from selling to each other to see what was really going on. They found out that not much selling was going on. Investors are still holding their shares. It will be interesting to see what their next approach will be to get investors to sell their shares.
Many prescriptions are written for many diseases that are off label without having an entire new study needing to be done.
Total nonsense!!!!
Nonsense- The safety of Isradipine was determined years ago.
If this study was a bust, believe me, it would have been discontinued a long time ago if only to save money and the time and effort it takes to do this type of study. It was already based on a positive observation and a preexploratory investigation prior to the official study. Also the study focused on why Isradipine actually really “worked” in the first place. The study was able to discern this as well and this information has previously been disclosed.
Writing an article for a medical journal will take at least til November, 2019. First this a long study with lots of data but also because their are many drafts, corrections, rewrites and resubmission before an article is accepted for official publication. The basic results will be leaked a long time before an official journal article. Based on what we know to date the results are positive.
N2k- Nice post!!!.
That 100 shares sold by a market maker drops the sp to .083 should tell you all you need to know if you are a seasoned OTC investor. Buy, hold, accumulate.
Just looking at the way they posted the chart to the right with the red line at the bottom tells you it’s going to be an up day .
The FDA is trying to do the right thing with SequestOx. Because SQO is a game changer for narcotics and will take over the narcotic industry and because this is a political mandate as well as a stated goal of the FDA, the FDA needs to make sure their is no pushback from BigPharma especially in light of all of the past bribes by BP. Nasrat is being careful because of the lawsuits being experienced by BP. BP could turn around and say look Elite is making narcotics too and should be included in the lawsuits really just to try to put Elite out of business. This is why Nasrat is also equally concentrating on the other drugs on tap because they will carry Elite through the period of additional testing for SQO. Everyone knows SQO will pass with flying colors but the FDA needs these test results to pushback against BP. Elite is playing a complicated chess game with BP. Be patient. Buy, hold, accumulate.
That's usually a Friday routine if Q is not good.
ELTP is no where near this position. Break out and upwards coming soon.
Always best to follow what insiders are doing with their shares. They are accumulating and paying themselves with more shares. How obvious could this be!
If there is a buyout, the FDA becomes a non-issue.
I agree. Ironic that shorts can't cover now. It would be justice that we wake up one morning and eltp was bought out and the buyout price was $5.00. Might ruin a few dark funds, overseas funds, and take down a market maker.